《Nature,6月25日,Assessing visible aerosol generation during vitrectomy in the era of Covid-19》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-06-29
  • Assessing visible aerosol generation during vitrectomy in the era of Covid-19

    Sidath Liyanage, Pathma Ramasamy, Omar Elhaddad, Kieren Darcy, Andrew Hudson & Johannes Keller

    Abstract

    Objective

    To assess visible aerosol generation during simulated vitrectomy surgery.

    Methods

    A model comprising a human cadaveric corneoscleral rim mounted on an artificial anterior chamber was used. Three-port 25 gauge vitrectomy simulated surgery was performed with any visible aerosol production recorded using high-speed 4K camera. The following were assessed: (1) vitrector at maximum cut rate in static and dynamic conditions inside the model, (2) vitrector at air–fluid interface in a physical model, (3) passive fluid–air exchange with a backflush hand piece, (4) valved cannulas under air, and (5) a defective valved cannula under air.

    Results

    No visible aerosol or droplets were identified when the vitrector was used within the model. In the physical model, no visible aerosol or droplets were seen when the vitrector was engaged at the air–fluid interface. Droplets were produced from the opening of backflush hand piece during passive fluid–air exchange. No visible aerosol was produced from the intact valved cannulas under air pressure, but droplets were seen at the beginning of fluid–air exchange when the valved cannula was defective.

  • 原文来源:https://www.nature.com/articles/s41433-020-1052-4
相关报告
  • 《Nature,6月22日,The end of social confinement and COVID-19 re-emergence risk》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-23
    • The end of social confinement and COVID-19 re-emergence risk Leonardo López & Xavier Rodó Nature Human Behaviour (2020) Abstract The lack of effective pharmaceutical interventions for SARS-CoV-2 raises the possibility of COVID-19 recurrence. We explore different post-confinement scenarios by using a stochastic modified SEIR (susceptible–exposed–infectious–recovered) model that accounts for the spread of infection during the latent period and also incorporates time-decaying effects due to potential loss of acquired immunity, people’s increasing awareness of social distancing and the use of non-pharmaceutical interventions. Our results suggest that lockdowns should remain in place for at least 60 days to prevent epidemic growth, as well as a potentially larger second wave of SARS-CoV-2 cases occurring within months. The best-case scenario should also gradually incorporate workers in a daily proportion at most 50% higher than during the confinement period. We show that decaying immunity and particularly awareness and behaviour have 99% significant effects on both the current wave of infection and on preventing COVID-19 re-emergence. Social distancing and individual non-pharmaceutical interventions could potentially remove the need for lockdowns.
  • 《Nature,6月19日,COVID-19 revisiting inflammatory pathways of arthritis》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-20
    • COVID-19 revisiting inflammatory pathways of arthritis Georg Schett, Bernhard Manger, David Simon & Roberto Caporali Nature Reviews Rheumatology (2020) Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease, caused by severe acute respiratory syndrome coronavirus 2, which predominantly affects the lungs and, under certain circumstances, leads to an excessive or uncontrolled immune activation and cytokine response in alveolar structures. The pattern of pro-inflammatory cytokines induced in COVID-19 has similarities to those targeted in the treatment of rheumatoid arthritis. Several clinical studies are underway that test the effects of inhibiting IL-6, IL-1β or TNF or targeting cytokine signalling via Janus kinase inhibition in the treatment of COVID-19. Despite these similarities, COVID-19 and other zoonotic coronavirus-mediated diseases do not induce clinical arthritis, suggesting that a local inflammatory niche develops in alveolar structures and drives the disease process. COVID-19 constitutes a challenge for patients with inflammatory arthritis for several reasons, in particular, the safety of immune interventions during the pandemic. Preliminary data, however, do not suggest that patients with inflammatory arthritis are at increased risk of COVID-19.